Shanghai Genext Medical Technology Co., Ltd.
PrivateLast Round
Series D
Extension
May 1, 2023
Est. Valuation
$125.94M
Total Funding Raised
$94.23M
Company Overview
Shanghai Genext Medical Technology Co., Ltd. is a medical technology company that provides products and professional services for the organ transplantation industry, including machine perfusion systems, cold storage solutions, and diagnostic reagents.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Pharma Supply Chain, Supply Chain Tracking
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Genext Medical Technology Co., Ltd. Comparables
Compare Shanghai Genext Medical Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bridge to Life | 81% | |
| Terumo Corporation | 81% | |
| Institut Georges Lopez | 81% | |
Shanghai Genext Medical Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | May 1, 2023 | ||||
| Series D | May 6, 2021 | ||||
| Strategic | Oct 20, 2020 | ||||
| Series C | Nov 4, 2019 | ||||
| Series B Extension | Mar 1, 2017 | ||||
Series B | Sep 8, 2016 |
Shanghai Genext Medical Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CCIC Capital | Series D, Strategic |
| Oriza Holdings | Series D |
| CCB International | Series C |
| Shengshan Asset Management | Strategic |
| 6 Dimensions Capital | Series B, Series A |
| Yunfeng Capital | Series D |
| Guangzhou Yuexiu Industrial Investment Fund Management | Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 6, 2021
$39M round with participation from Oriza Holdings and Yunfeng Capital.
- Oct 20, 2020
Raised capital from Shengshan Asset Management and CCIC Capital.
Shanghai Genext Medical Technology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shanghai Genext Medical Technology Co., Ltd.'s valuation, stock price, and market status.